Florida Eye Institute Blog

Florida Eye Institute Safely Resumes Cataract and ‘Elective’ Surgery

Have you wondered why some surgeries are considered “elective” and why your cataract surgery may have been canceled during the COVID shutdown? According to Johns Hopkins Medicine, ‘elective’ does not necessarily mean ‘optional’.  Elective surgery simply means the procedure can be scheduled in advance. In the case of cataract surgery, that often means when cataract interferes with daily activities like driving, recreation, and work. But delaying cataract surgery may greatly impact patient safety. Studies show an increased risk of car accidents and hip fractures when appropriate cataract surgery is delayed. Recently, elective surgeries were canceled or postponed in Florida due to the Coronavirus pandemic to safeguard patients and to reduce the use of PPE (personal protective equipment) for medical professionals. Postponing scheduled outpatient procedures helped keep PPE available for those professionals working in front line response to COVID-19. The Executive order to resume all procedures in Florida was approved for May 4, 2020. In the coming weeks and months, you will find that additional safety precautions are implemented to mitigate the spread of the novel coronavirus including temperature checks, facial coverings, and social distancing in most public settings. If you are ready to reschedule your cataract surgery call (772) 500-2020

Read More »

The New Normal for Patient Safety in Eye Care

Eye care and cataract surgery have always been considered safe. In fact, of all out-patient procedures performed in the United States today, cataract surgery remains one of the safest and most frequently performed. A recent study of 200,000 Medicare beneficiaries confirmed that 99.5 percent experienced no severe postoperative complications after cataract surgery. But you may wonder how the current COVID reality changes safety considerations for those seeking eye care and surgery, especially as restrictions on out-patient surgery and medical office visits are lifted throughout the state. Florida Eye Institute is actively implementing current recommendations from the  CDC and the Florida Department of Health as our offices resume full services. Victor Basile, Administrator confirms, “This extraordinary time has fortified our mission to serve all patients, community, and staff with the utmost concern for excellence and safety. We’ve been working nonstop to update our protocols based on the latest advisories from medical experts.” During your next visit, you will notice several new procedures to ensure everyone’s safety and wellbeing. temperature checks for patients and staff entering the facility reduced waiting room capacity for social distancing enhanced cleaning procedures masks for employees in patient care areas patients are asked to wear their own

Read More »

Essential Sight Saving Treatments in the Midst of COVID Crisis

Patients with sight limiting diseases like Macular Degeneration know the importance of regular treatments to preserve existing vision. The most common treatments to slow vision loss from wet macular degeneration are anti-VEGF intravitreal injections. These drugs are considered the first-line treatment for all stages of wet macular degeneration and are typically scheduled every 4-6 weeks to maintain effectiveness. That all changed in the past month with the outbreak of COVID-19. Both the American Academy of Ophthalmology and CDC have advised limited medical office visits to minimize risk and exposure to the novel coronavirus for patients and staff. To accommodate the situation, Florida Eye Institute quickly prioritized procedures to continue providing care for their most vulnerable patient populations. “Continuing to treat vision-threatening illness is our top priority even under these difficult circumstances,” confirms Dr. Thomas Baudo, a fellowship-trained retina ophthalmologist at Florida Eye Institute. Retina specialists are frequently on the front lines of urgent care for sight limiting conditions like macular tears, detachments and macular degeneration. Victor Basile, Administrator for the multi-specialty practice adds, “We instituted policies as soon as the CDC recommendations came out. Whereas normally, we see hundreds of patients a day for glaucoma monitoring, corneal disease, cataract consultations

Read More »

Florida Eye Institute Hosts “Meet the Doctor” Lunch & Learn Seminars

Learn about the latest trends in ophthalmology during the Meet the Doctor seminar series at Florida Eye Institute. Enjoy a light lunch and discover how laser advancements and surgical options can improve vision like never before. All seminars are FREE and open to the public. Friday, Feb. 28, 2020: NEW! FDA Approved BEOVU for Macular Degeneration. Thomas Baudo, MD, Board Certified Ophthalmology Learn about the latest treatment in the fight against wet macular degeneration, the leading cause of severe and irreversible vision loss for adults over 65. Friday, March 6, 2020: Glaucoma Update 2020 – Amazing Micro-Stents. Karen Todd, MD, Board Certified Ophthalmology Can a tiny stent reduce the need for daily glaucoma eye drops? Dr. Todd discusses the latest micro-surgical options that can be completed during cataract surgery. Are they for you? Friday, March 13, 2020: “HELP, Herpes! The Doctor Says It’s My Cornea” Christopher Shumake, MD, Board Certified Ophthalmology How to know if pain, redness, or rash on the eyelids is simple irritation or a potentially damaging virus? Dr. Shumake explains common conditions of the cornea and how to protect your vision. Friday, March 20, 2019: Can a Laser Cure My Floaters?  Thomas Baudo, MD, Board Certified Ophthalmology

Read More »

NEW! FDA Treatment BEOVU for Wet Macular Degeneration

The Macular Degeneration and Diabetes Center of Florida Eye Institute offers the latest FDA approved Beovu injection for patients with wet macular degeneration. Wet AMD is the leading cause of severe vision loss and legal blindness for people over the age of 65. It’s estimated 1.75 million people in the U.S. will be living with wet AMD in 2020. Beovu was approved October 8, 2019 by the Food and Drug Administration and is the newest option to treat the potentially blinding effects of wet macular degeneration affecting nearly 1.75 million Americans over the age of sixty. In clinical trials, patients achieved greater visual gains and fluid reduction with quarterly dosing schedules of Beovu compared to other medications with 4-6-week injection timetables.  “I am excited about this latest advance to treat patients with macular degeneration” says Dr. Thomas Baudo, fellowship trained retina physician and surgeon with Florida Eye Institute in Vero Beach, FL. “Beovu was engineered to deliver a higher concentration of drug binding agents, suppressing the growth of abnormal blood vessels that leak excess fluid into the retina and cause visual distortion. It’s the first FDA approved medication to offer less frequent dosing in the first year while maintaining clinical

Read More »

Florida Eye Institute Surgeons Certified in New Hydrus Microstent for Glaucoma

Florida Eye Institute cataract surgeons Karen Todd, MD and Val Zudans, MD,  have successfully demonstrated the technical knowledge to implant the Hydrus Microstent according to certification by Richard Hope, MD, Vice President of Clinical and Medical Affairs at Ivantis. Hydrus is the latest FDA approved minimally invasive glaucoma surgery (MIGS) device used for the treatment of mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. “The Hydrus Microstent has proven to be a reliable option to reduce dependence on pressure lowering drops for our glaucoma patients,” states Karen Todd, MD, Board Certified Ophthalmologist, fellowship trained in glaucoma. “We have searched a long time for the right minimally invasive, effective solution for open-angle glaucoma patients. Hydrus provides a convenient way to achieve two extremely positive outcomes with one surgery – removal of cataract and reduction of intra-ocular pressure.” Dr. Val Zudans, Board Certified Ophthalmologist, cataract and refractive surgeon adds, “We are really impressed with the clinical findings. Recent studies show nearly 78% of Hydrus patients achieved a statistically significant decrease (≥ 20 percent reduction in unmedicated IOP) at 24-months postoperative. This represents the largest improvement over a control group in any MIGS trial to date.” There are several options

Read More »

Diabetes Awareness Fact – 95% of related vision loss can be prevented with regular exams.

Diabetes can significantly increase your risk of vision loss.  It’s estimated that 45% of individuals with diabetes already have some form of eye disease, yet most do not schedule annual, sight-saving exams according to a large study. Florida Eye Institute emphasizes the importance of healthy vision this November, nationally recognized as Diabetes Awareness Month. Learn how diabetes impacts your risk eye disease during an informative seminar presented by Dr. Thomas Baudo, fellowship-trained retina specialist, on Friday November 15 at 1:00 PM. Diabetic eye disease is a group of conditions that includes retinopathy, diabetic macular edema (DME), cataract, and glaucoma. Fluctuating blood sugar creates fragile, abnormal blood vessels that grow and leak within the eye, distorting vision. Distortions can advance to blindness if left untreated. Researchers at Wills Eye Hospital in Philadelphia discovered that more than half of those with diabetes skip annual eye exams. Smokers were most likely to neglect check-ups and consequently show signs of diabetic eye disease. Other findings include: Fifty-eight percent of patients did not have regular eye exams Smokers were 20 percent less likelyto have exams Those with moderate disease and no current vision loss were least likely to follow recommendations Those diagnosed with diabetic retinopathy were 30 percent more likely to

Read More »

Florida Eye Institute Hosts “Meet the Doctor” Lunch & Learn Series

All Seminars are FREE and Open to the Public. Meet the Doctor seminars at  Florida Eye Institute are scheduled Friday November 15th and 22nd. Discover the latest trends in ophthalmology  and learn how advanced options can improve vision like never before. Lectures begin at 1:00 PM with registration at 12:30 PM. A light lunch will be provided. Call 772-569-9500 to RSVP as space is limited.

Read More »

Florida Eye Institute to Announce Grand Prize Photo Contest Winner at Centennial Finale

  To celebrate 35 years of vision in the community and commemorate the Vero Beach Centennial, Florida Eye Institute devised a year-long photo contest aptly titled My2020Experience. A special website was created expressly for the contest according to Cindi Green, RN, APR, Director of Marketing and Community Relations for the ophthalmology practice. “Since we’re known for helping people experience their best vision, it was a perfect way to showcase the diversity of our area during this extraordinary year,” she confirms. “We received outstanding photos of stunning sunsets, vibrant flowers, and people enjoying outdoor activities each month during the contest. It will definitely be a challenge to select the final grand prize winner!” If you would like to share your vision of Vero Beach, upload photos directly to My2020Experience.com. The Grand Prize winner will be announced at the Centennial Finale on Saturday, October 26, 2019, and awarded $250 cash courtesy of Florida Eye Institute. “There’s still time to enter so get out there and share your vision of all things Centennial!” confirms Green. More information can be found at My2020Experience.com Florida Eye Institute specializes in comprehensive eye care including custom cataract surgery, glaucoma treatment, macular degeneration and diabetic eye conditions with

Read More »